Detalhe da pesquisa
1.
Learning from organisational changes in the management of breast cancer patients during the COVID-19 pandemic: Preparing for a second wave at a breast unit in northern Italy.
Int J Health Plann Manage
; 36(4): 1030-1037, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33890324
2.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31747948
3.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31029508
4.
Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.
Anticancer Drugs
; 28(6): 654-659, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28252532
5.
Integrating mHealth in Oncology: Experience in the Province of Trento.
J Med Internet Res
; 17(5): e114, 2015 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-25972226
6.
Supporting patients and clinicians during the breast cancer care path with AI: The Arianna solution.
Artif Intell Med
; 138: 102514, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36990591
7.
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?
Semin Oncol
; 50(3-5): 90-101, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37673696
8.
Whole Breast Irradiation Versus Intraoperative Electron Radiation Therapy for Breast Conserving Therapy: A Large Mature Single Institution Matched-Pair Evaluation of True Local Relapse, Progression Free Survival, and Overall Survival.
Int J Radiat Oncol Biol Phys
; 116(4): 757-769, 2023 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36736632
9.
Integrating extracellular vesicle and circulating cell-free DNA analysis using a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients.
J Extracell Biol
; 2(9)2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-38046436
10.
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.
Eur J Cancer
; 181: 92-101, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36641898
11.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37260975
12.
Rethinking breast cancer follow-up based on individual risk and recurrence management.
Cancer Treat Rev
; 109: 102434, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35933845
13.
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.
Target Oncol
; 17(6): 615-625, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36152144
14.
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.
NPJ Breast Cancer
; 8(1): 33, 2022 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35314692
15.
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.
Breast Cancer Res Treat
; 128(1): 147-54, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21479926
16.
Exploring metastatic breast cancer treatment changes during COVID-19 pandemic.
J Chemother
; 33(4): 263-268, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33047649
17.
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience.
JCO Oncol Pract
; 17(1): e44-e52, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33351674
18.
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial.
Eur J Cancer
; 154: 21-29, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34225066
19.
Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.
Int J Gynecol Cancer
; 20(6): 953-7, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20683401
20.
Embedding oncologic protocols into the provision of care: the Oncocure project.
Stud Health Technol Inform
; 150: 663-7, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19745394